TEVA stock fundamentals - cash flow

Cash Flow

capital Expenditures --139,000,000
cash Change 2,143,000,000
cash Flow --145,000,000
cash Flow Financing --706,000,000
changes In Inventories 4,118,000,000
changes In Receivables 3,435,000,000
currency USD
depreciation 304,000,000
filing Type 10-Q
fiscal Date 2023-03-31
fiscal Quarter 1
fiscal Year 2023

fiscal Year 2023
net Borrowings 16,753,000,000
net Income --205,000,000
report Date 2023-05-10
symbol TEVA
total Investing Cash Flows 181,000,000
id CASH_FLOW
key TEVA
subkey quarterly
date 2023-03-31
updated 2023-05-18

News on the web

Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts

10 Days ago TipRanks

Teva, Astera, Coinbase, Crocs, PDD: Trending by Analysts

24 Days ago TipRanks

Investor Stanley Druckenmiller Sells Alphabet (GOOGL) Stake, Loads Up on Taiwan Semi

25 Days ago TipRanks

Teva (NYSE:TEVA) Delivers Q4 Beat; To Divest API Unit

496 Days ago TipRanks

Options Volatility and Implied Earnings Moves Today, January 31, 2024

496 Days ago TipRanks

Corcept (NASDAQ:CORT) Faces Setback in Patent Case; Shares Decline

526 Days ago TipRanks

HSBC Sees Opportunity in These 2 Biopharma Giants Ahead of the 2024 Elections

532 Days ago TipRanks

Teva Pharmaceutical (NYSE:TEVA) Says Business Unaffected by Israel-Palestine War

609 Days ago TipRanks

Here’s Why Teva Stock (NYSE:TEVA) Fell and Then Rose Yesterday

658 Days ago TipRanks